These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 36511290

  • 1. Identification of neutralizing epitopes in the preS2 domain of the hepatitis B virus.
    Yato K, Matsuda M, Fukano K, Tanaka T, Moriishi K, Nishitsuji H, Shimotohno K, Tamura K, Wakita T, Muramatsu M, Kato T, Suzuki R.
    Virus Res; 2023 Jan 02; 323():199014. PubMed ID: 36511290
    [Abstract] [Full Text] [Related]

  • 2. Both middle and large envelope proteins can mediate neutralization of hepatitis B virus infectivity by anti-preS2 antibodies: escape by naturally occurring preS2 deletions.
    Zhang J, Wang Q, Yuan W, Li J, Yuan Q, Zhang J, Xia N, Wang Y, Li J, Tong S.
    J Virol; 2024 Aug 20; 98(8):e0192923. PubMed ID: 39078152
    [Abstract] [Full Text] [Related]

  • 3. Identification of Two Critical Neutralizing Epitopes in the Receptor Binding Domain of Hepatitis B Virus preS1.
    Yato K, Onodera T, Matsuda M, Moriyama S, Fujimoto A, Watashi K, Aizaki H, Tanaka T, Moriishi K, Nishitsuji H, Shimotohno K, Tamura K, Takahashi Y, Wakita T, Muramatsu M, Kato T, Suzuki R.
    J Virol; 2021 Mar 01; 95(5):. PubMed ID: 33298539
    [Abstract] [Full Text] [Related]

  • 4. Discrimination of hepatitis B virus (HBV) subtypes using monoclonal antibodies to the PreS1 and PreS2 domains of the viral envelope.
    Mimms LT, Floreani M, Tyner J, Whitters E, Rosenlof R, Wray L, Goetze A, Sarin V, Eble K.
    Virology; 1990 Jun 01; 176(2):604-19. PubMed ID: 1693248
    [Abstract] [Full Text] [Related]

  • 5. Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide.
    Yan H, Peng B, Liu Y, Xu G, He W, Ren B, Jing Z, Sui J, Li W.
    J Virol; 2014 Mar 01; 88(6):3273-84. PubMed ID: 24390325
    [Abstract] [Full Text] [Related]

  • 6. Establishment of a Monoclonal Antibody against Human NTCP That Blocks Hepatitis B Virus Infection.
    Takemori T, Sugimoto-Ishige A, Nishitsuji H, Futamura Y, Harada M, Kimura-Someya T, Matsumoto T, Honma T, Tanaka M, Yaguchi M, Isono K, Koseki H, Osada H, Miki D, Saito T, Tanaka T, Fukami T, Goto T, Shirouzu M, Shimotohno K, Chayama K.
    J Virol; 2022 Mar 09; 96(5):e0168621. PubMed ID: 34985994
    [Abstract] [Full Text] [Related]

  • 7. N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus.
    Bremer CM, Sominskaya I, Skrastina D, Pumpens P, El Wahed AA, Beutling U, Frank R, Fritz HJ, Hunsmann G, Gerlich WH, Glebe D.
    J Hepatol; 2011 Jul 09; 55(1):29-37. PubMed ID: 21145866
    [Abstract] [Full Text] [Related]

  • 8. Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective.
    Neurath AR, Seto B, Strick N.
    Vaccine; 1989 Jun 09; 7(3):234-6. PubMed ID: 2476893
    [Abstract] [Full Text] [Related]

  • 9. Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection.
    Cornelius C, Schöneweis K, Georgi F, Weber M, Niederberger V, Zieglmayer P, Niespodziana K, Trauner M, Hofer H, Urban S, Valenta R.
    EBioMedicine; 2016 Sep 09; 11():58-67. PubMed ID: 27568223
    [Abstract] [Full Text] [Related]

  • 10. Molecular analysis of Hepatitis B virus sub-genotypes and incidence of preS1/preS2 region mutations in HBV-infected Egyptian patients from Mansoura.
    El-Mowafy M, Elgaml A, El-Mesery M, Elegezy M.
    J Med Virol; 2017 Sep 09; 89(9):1559-1566. PubMed ID: 28390175
    [Abstract] [Full Text] [Related]

  • 11. Hepatitis B defective virus with rearrangements in the preS gene during chronic HBV infection.
    Gerken G, Kremsdorf D, Capel F, Petit MA, Dauguet C, Manns MP, Meyer zum Büschenfelde KH, Brechot C.
    Virology; 1991 Aug 09; 183(2):555-65. PubMed ID: 1853561
    [Abstract] [Full Text] [Related]

  • 12. The machinery for endocytosis of epidermal growth factor receptor coordinates the transport of incoming hepatitis B virus to the endosomal network.
    Iwamoto M, Saso W, Nishioka K, Ohashi H, Sugiyama R, Ryo A, Ohki M, Yun JH, Park SY, Ohshima T, Suzuki R, Aizaki H, Muramatsu M, Matano T, Iwami S, Sureau C, Wakita T, Watashi K.
    J Biol Chem; 2020 Jan 17; 295(3):800-807. PubMed ID: 31836663
    [Abstract] [Full Text] [Related]

  • 13. [Novel vector preS1-tp fusion protein effectively inhibits hepatitis B virus replication and cccDNA synthesis by mediating hepatitis B virus targeting sequence small interfering RNA].
    Zeng YL, Gao F, Zhang C, Wei JF, Ma L, Ding GG, Li W, Shang J, Kang Y.
    Zhonghua Gan Zang Bing Za Zhi; 2021 Feb 20; 29(2):126-132. PubMed ID: 33685080
    [Abstract] [Full Text] [Related]

  • 14. Kinetics of the bile acid transporter and hepatitis B virus receptor Na+/taurocholate cotransporting polypeptide (NTCP) in hepatocytes.
    König A, Döring B, Mohr C, Geipel A, Geyer J, Glebe D.
    J Hepatol; 2014 Oct 20; 61(4):867-75. PubMed ID: 24845614
    [Abstract] [Full Text] [Related]

  • 15. Antibodies to synthetic peptides from the pre-S1 and pre-S2 regions of one subtype of the hepatitis B virus (HBV) envelope protein recognize all HBV subtypes.
    Neurath AR, Kent SB, Strick N, Parker K, Courouce AM, Riottot MM, Petit MA, Budkowska A, Girard M, Pillot J.
    Mol Immunol; 1987 Sep 20; 24(9):975-80. PubMed ID: 3657811
    [Abstract] [Full Text] [Related]

  • 16. In vitro neutralization of hepatitis B virus by monoclonal antibodies against the viral surface antigen.
    Ryu CJ, Gripon P, Park HR, Park SS, Kim YK, Guguen-Guillouzo C, Yoo OJ, Hong HJ.
    J Med Virol; 1997 Jun 20; 52(2):226-33. PubMed ID: 9179773
    [Abstract] [Full Text] [Related]

  • 17. Applications of human hepatitis B virus preS domain in bio- and nanotechnology.
    Toita R, Kawano T, Kang JH, Murata M.
    World J Gastroenterol; 2015 Jun 28; 21(24):7400-11. PubMed ID: 26139986
    [Abstract] [Full Text] [Related]

  • 18. Recognition of hepatitis B virus envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection.
    Barnaba V, Franco A, Alberti A, Balsano C, Benvenuto R, Balsano F.
    J Immunol; 1989 Oct 15; 143(8):2650-5. PubMed ID: 2477450
    [Abstract] [Full Text] [Related]

  • 19. A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide.
    Kaneko M, Watashi K, Kamisuki S, Matsunaga H, Iwamoto M, Kawai F, Ohashi H, Tsukuda S, Shimura S, Suzuki R, Aizaki H, Sugiyama M, Park SY, Ito T, Ohtani N, Sugawara F, Tanaka Y, Mizokami M, Sureau C, Wakita T.
    J Virol; 2015 Dec 15; 89(23):11945-53. PubMed ID: 26378168
    [Abstract] [Full Text] [Related]

  • 20. Mapping of immunodominant B-cell epitopes and the human serum albumin-binding site in natural hepatitis B virus surface antigen of defined genosubtype.
    Sobotta D, Sominskaya I, Jansons J, Meisel H, Schmitt S, Heermann KH, Kaluza G, Pumpens P, Gerlich WH.
    J Gen Virol; 2000 Feb 15; 81(Pt 2):369-78. PubMed ID: 10644835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.